Clinical Practice Session

Adherence and Hypertension: Can Antihypertensives Work in Patients Who Don't Take Them?

November 09, 2019 | 02:00 PM - 04:00 PM

Location: 202, Walter E. Washington Convention Center

Session Description

Nonadherence is a huge issue, especially in hypertension. Research suggests there is unintentional nonadherence (e.g., forgetfulness) that can be detected by calling the pharmacy or counting pills, but intentional nonadherence is a different phenotype. Direct measures of adherence, such as therapeutic drug monitoring or directly observed therapy, are being used more commonly. Patient viewpoint is also important; this is not a “blame the patient” area. Clinicians need to understand and develop effective strategies.

Learning Objective(s)

  • Explain the importance of nonadherence in the diagnosis and management of hypertension
  • Describe the accuracy and logistics of different measures of nonadherence
  • Discuss the patient viewpoint on why nonadherence occurs
  • Develop strategies to address nonadherence

Learning Pathway(s)

  • Hypertension and CVD
  • Chronic Kidney Disease

Moderator(s)

  • Vimal K. Derebail, MD, MPH, FASN
  • James M. Luther, MD, FASN

Presentations

  • The Spectrum of Nonadherence in Hypertension
    02:00 PM - 02:30 PM
    Sandra J. Taler, MD
  • The Phenotype of Intentional Nonadherence and the Role of Direct Measurement
    02:30 PM - 03:00 PM
    Marcel Ruzicka, MD, PhD
  • Nonadherence: A Patient Viewpoint
    03:00 PM - 03:30 PM
    Gabi Morales
  • Self-Monitoring and Adherence
    03:30 PM - 04:00 PM
    Richard James Magnus McManus, MA, MBBS, PhD